Announce Date | 01/28/2025 |
EPS Normalized Actual | $4.01 (Beat by $0.14) |
EPS GAAP Actual | $4.01 (Beat by $0.14) |
Revenue Actual | $6.436B |
Revenue Surprise | Beat by $6436M |
Announce Date | 06/30/2025 (Pre-Market) |
EPS Normalized Estimate | $3.18536 |
EPS GAAP Estimate | $3.18536 |
Revenue Estimate | $5.778850976B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 20.54 | 17.77 | 20.17113 | 20.87161 | 1 |
Dec 2028 | 17.74 | 20.58 | 12.96778 | 18.53485 | 3 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ4 2024 (Dec 2024) | 1.43 | 1.43 | 6.436B | 9.65% | 6436M |
FQ3 2024 (Sep 2024) | 2.19 | 2.19 | 5.494B | 10.65% | 5494M |
FQ2 2024 (Jun 2024) | 2.17 | 2.17 | 5.422B | 7.86% | 5422M |
FQ1 2024 (Mar 2024) | 2.07 | 2.07 | 5.243B | 8.87% | 5243M |
FQ4 2023 (Dec 2023) | 3.01 | 3.01 | 5.815B | 10.54% | 5815M |
FQ3 2023 (Sep 2023) | 1.82 | 1.82 | 4.909B | 100% | 4909M |
FQ2 2023 (Jun 2023) | 1.94 | 1.94 | 4.996B | 10.07% | 4996M |
FQ1 2023 (Mar 2023) | 1.56 | 1.56 | 4.778B | 100% | 4778M |
FQ4 Announce Date
06/30/2025 (Pre-Market)
Consensus EPS Estimates
3.18536
Consensus Revenue Estimates
5.778850976B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 4.05651 | -- | 3.96823 | 4.16357 | 10 |
FQ2 2027 (Jun 2027) | 3.95171 | -- | 3.86571 | 4.056 | 7 |
FQ1 2027 (Mar 2027) | 3.45071 | -- | 3.38061 | 3.54696 | 8 |
FQ4 2026 (Oct 2026) | 3.50126 | -- | 3.46974 | 3.55436 | 7 |
FQ3 2026 (Jul 2026) | 3.50438 | -- | 3.47283 | 3.55753 | 12 |
FQ2 2026 (Jun 2026) | 3.45215 | -- | 3.30295 | 3.54168 | 12 |
FQ1 2026 (Mar 2026) | 3.06314 | -- | 2.93075 | 3.14258 | 7 |
FQ4 2025 (Oct 2025) | 3.15434 | 54.67 | 3.12594 | 3.20218 | 8 |
FQ3 2025 (Jul 2025) | 3.18011 | 31.13 | 3.15148 | 3.22834 | 9 |
FQ2 2025 (Jun 2025) | 3.18536 | 31.88 | 3.04769 | 3.26797 | 9 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 6.85B | -- | 6.73B | 6.99B | 7 |
FQ2 2027 (Jun 2027) | 6.75B | -- | 6.64B | 6.89B | 7 |
FQ1 2027 (Mar 2027) | 6.53B | -- | 6.42B | 6.67B | 7 |
FQ4 2026 (Oct 2026) | 6.18B | -- | 6.14B | 6.25B | 8 |
FQ3 2026 (Jul 2026) | 6.27B | -- | 6.23B | 6.34B | 13 |
FQ2 2026 (Jun 2026) | 6.17B | -- | 5.96B | 6.29B | 8 |
FQ1 2026 (Mar 2026) | 5.82B | -- | 5.63B | 5.94B | 10 |
FQ4 2025 (Oct 2025) | 5.74B | -12.16 | 5.7B | 5.81B | 7 |
FQ3 2025 (Jul 2025) | 5.81B | 5.43 | 5.77B | 5.88B | 8 |
FQ2 2025 (Jun 2025) | 5.78B | 6.18 | 5.59B | 5.89B | 7 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | 1.43 | 1.43 | 100% | |
FQ3 2024 (Sep 2024) | 2.19 | 2.19 | 100% | |
FQ2 2024 (Jun 2024) | 2.17 | 2.17 | 100% | |
FQ1 2024 (Mar 2024) | 2.07 | 2.07 | 100% | |
FQ4 2023 (Dec 2023) | 3.01 | 3.01 | 100% | |
FQ3 2023 (Sep 2023) | 1.82 | 1.82 | 100% | |
FQ2 2023 (Jun 2023) | 1.94 | 1.94 | 100% | |
FQ1 2023 (Mar 2023) | 1.56 | 1.56 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | $0B | $6.44B | $6436M | 100% |
FQ3 2024 (Sep 2024) | $0B | $5.49B | $5494M | 100% |
FQ2 2024 (Jun 2024) | $0B | $5.42B | $5422M | 100% |
FQ1 2024 (Mar 2024) | $0B | $5.24B | $5243M | 100% |
FQ4 2023 (Dec 2023) | $0B | $5.82B | $5815M | 100% |
FQ3 2023 (Sep 2023) | $0B | $4.91B | $4909M | 100% |
FQ2 2023 (Jun 2023) | $0B | $5B | $4996M | 100% |
FQ1 2023 (Mar 2023) | $0B | $4.78B | $4778M | 100% |